The views and opinions expressed in the interviews published on Made in CA are those of the interviewees and do not reflect the official policy or position of Made in CA.

The information provided through these interviews is for informational purposes only and does not constitute an endorsement or recommendation of any products, services, or individuals featured. We strongly encourage readers to consult with appropriate professionals or authorities in the relevant fields for accurate information and advice.

Bassem Toeama

MD Pharma Consulting Group supports stakeholders working in the pharmaceutical, biotechnology, healthcare, medical research, and scholarly publications industries to provide comprehensive, evidence-based, cost-efficient care to our patients. We are collaborators, not competitors. We streamline clinical operations to provide efficacious solutions for complex projects from “Bench” side to “Market” side. Our values include quality, commitment, reliability, excellence, integrity, satisfaction, and professionalism. Our mission is the promotion of human well-being, the development of new trends in the biopharmaceutical and medical device industry, and supporting the development of drugs, vaccines, and medical devices from discovery through post-approval

Tell us about yourself?

I graduated in medicine and have worked in clinical medicine as an oncologist, in academia, and in the pharmaceutical, biotechnology, and drug development industry over the past 25 years. My experience has been primarily in oncology, medical writing and scholarly communications, pharmacovigilance, clinical research, lab research, and continuous professional development. I hold an MSc degree in Experimental Therapeutics from the University of Oxford, UK, an MSc degree in Experimental Medicine at McGill University, Canada, and I am a PhD candidate in health technology assessment at the University of Toronto, Canada. I leveraged my experience as a clinician, clinical researcher, pharmacovigilance consultant, medical writer, and/or health economist and integrated that with my academic mindset and industrial background to bridge the gap between academia and industry. I am the CEO and Founder of MD Pharma Consulting Group Inc., managing a professional team experienced in medical and scientific writing, publications and scholarly communications, clinical research, pharmacovigilance, and health economics and outcomes research to provide top-notch quality evidence-based scientific and medical services to our stakeholders. My main areas of research are internal medicine, medical oncology, epidemiology, pharmacovigilance, health technology assessment, decision analysis, and benefit-risk assessment.

If you could go back in time a year or two, what piece of advice would you give yourself?

Keep on going, and never give up! Reach out to others, assess the market needs, address the uncertainty, and showcase myself and my company as a solution provider, and wish peace and happiness to everyone.

What problem does your business solve?

Incepted in 2018, MD Pharma Consulting Group Inc.’s operational headquarters in Canada has been supporting stakeholders in North America, collaborating with them on diverse medical consultation, pharmacovigilance, and health economics and outcomes research projects. As a result of our enterprising approach, we have grown steadily despite challenging market conditions.

What is the inspiration behind your business?

​Everything we do at MD Pharma Consulting Group is for the patient. Patients are our inspiration. MD Pharma Consulting Group is a science-driven, quality-focused market leader that provides innovative consultations and executive solutions to diverse pharmaceutical, biotechnology, and medical device industry stakeholders. Pharmacovigilance, medical affairs, risk management, medical monitoring, data management, product management, statistics and data analysis, health economic outcomes research, and medical writing outline our scope of clinical research and post-market deliverables.

What is your magic sauce?

We have a global outreach with our principal place of business (operational headquarters) located in the GTA, ON, Canada and our subsidiary’s place of business (regional office) located in Cairo, Egypt. Our team is qualified, diverse and brings top-notch quality and cost-efficient solutions to our diverse stakeholders. MD Pharma Consulting Group is resourceful, analytical, insightful, developer, visionary, strategic, supportive, quality control, quality assurance, and stakeholder-oriented.

What is the plan for the next 5 years? What do you want to achieve?

Our vision is to become an influential key player in the biopharmaceutical and medical device industries. We want to embrace a paradigm shift in the role of contract research organizations and set up a new benchmark for Contract Research Organizations. In five years, MD Pharma Consulting Group will position itself as one of the leading global contract research organizations in North America, the Middle East, and the North African region.

What is the biggest challenge you’ve faced so far?

The COVID-19 pandemic and the associated uncertainty were the biggest challenges we faced in North America. The business slowed down in North America, so we moved on and approached emerging markets in the Middle East and North African region. By far, MD Pharma is in a better state now!

How can people get involved?

Our diverse stakeholders can schedule a call with our team to discuss their specific requirements. They can contact us today by phone at +1 (905) 315-5043, +1 (514) 578-6780, +20 2 2461 8603, +20 112 225 7818, email us at and, or through the convenient contact forms at and at